SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001973141-23-000076
Filing Date
2023-06-09
Accepted
2023-06-09 16:28:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3491
  Complete submission text file 0001973141-23-000076.txt   4775
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Subject) CIK: 0001664710 (see all company filings)

IRS No.: 811173868 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39264 | Film No.: 231005702
SIC: 2834 Pharmaceutical Preparations

Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address
Regnante Keith (Reporting) CIK: 0001682068 (see all company filings)

Type: 144